Macquarie Group LTD Cue Biopharma, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.24 - $2.18 $2,238 - $3,934	1,805 New	1,805 $2,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $14,957 - $35,561	-6,007 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $21,817 - $35,860	-2,009 Reduced 25.06%	6,007 $68,000
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $74,262 - $112,944	7,382 Added 1164.35%	8,016 $117,000
Q1 2021 May 14, 2021	SELL	$11.2 - $16.09 $2,184 - $3,137	-195 Reduced 23.52%	634 $8,000
Q2 2020 Aug 11, 2020	BUY	$12.7 - $30.73 $10,528 - $25,475	829 New	829 $20,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.